Subscribe To
TNDM / Strength Seen in Tandem Diabetes Care, Inc. (TNDM): Can Its 8.9% Jump Turn into More Strength?
TNDM News
By Seeking Alpha
November 1, 2023
Tandem Diabetes Care, Inc. (TNDM) Q3 2023 Earnings Call Transcript
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Susan Morrison - EVP & Chi more_horizontal
By Zacks Investment Research
November 1, 2023
Compared to Estimates, Tandem Diabetes Care, Inc. (TNDM) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended September 2023, it more_horizontal
By Zacks Investment Research
October 16, 2023
Tandem Diabetes Care, Inc. (TNDM) Soars 6.0%: Is Further Upside Left in the Stock?
Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions more_horizontal
By Zacks Investment Research
October 9, 2023
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
Investors remain optimistic about Tandem Diabetes (TNDM), backed by strategic developments and innovative new launches. more_horizontal
By Zacks Investment Research
August 25, 2023
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
Investors continue to be optimistic about Tandem Diabetes (TNDM) due to the t:slim X2 insulin pump and new product innovations. more_horizontal
By Zacks Investment Research
August 4, 2023
Tandem Diabetes (TNDM) Reports Narrower Q2 Loss, Trims '23 View
Tandem Diabetes' (TNDM) second-quarter 2023 performance reflects new technology innovations and operational improvements throughout its business. more_horizontal
By Zacks Investment Research
August 3, 2023
Compared to Estimates, Tandem Diabetes Care, Inc. (TNDM) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended June 2023, it might more_horizontal
By Zacks Investment Research
August 3, 2023
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compa more_horizontal